Intrater James 4
4 · Cardio Diagnostics Holdings, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Cardio Diagnostics (CDIO) Director James Intrater Receives 2,854-Share Award
What Happened James Intrater, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was granted 2,854 derivative shares on June 30, 2026. The award is reported as transaction code "A" (grant/award) and is listed at $2.19 per share, for a total reported value of approximately $6,250. This was an award of derivative securities (e.g., RSUs or similar), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-30; Filing date (Form 4): 2026-07-02 — appears to be filed timely (within 2 business days).
- Transaction type/code: A = Award/Grant of derivative securities.
- Shares granted/acquired: 2,854 derivative shares at $2.19 each; total reported value ≈ $6,250.
- Shares owned after transaction: Not specified in the provided excerpt — see the full Form 4 for post-transaction beneficial holdings.
- Footnotes/other: No 10b5-1 plan, tax-withholding, or additional footnotes listed in the provided transaction details.
Context An "A" award of derivative securities typically reflects a compensation grant (such as restricted stock units or similar) rather than an outright purchase or sale. Such grants are common for directors and may vest over time; they do not necessarily indicate a buy/sell market signal. For complete details (vesting schedule, conversion to common shares, and exact post-transaction holdings), consult the full Form 4 linked by the SEC accession number.
Insider Transaction Report
- Award
Stock Options (Right to Buy)
2026-06-30$2.19/sh+2,854$6,250→ 13,318 totalExercise: $2.19From: 2026-06-30Exp: 2036-06-30→ Common Stock (2,854 underlying)